SEELY LYNN purchased 32.6% of their position (175K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market purchase worth $106.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/18/2025ACC: 0001415889-25-008509
+175K
Net shares
Net buyer
$106.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
175K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+175K
Price / share
$0.61
Trade value
$106.19K
% of position
32.6%
3/14/2025
537.50K→712.50K
Total
Net shares
+175K
Net value
$106.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2025 | P · Purchase | +175K | $0.61 | $106.19K | 32.6% | 537.50K | 712.50K |
| Total | +175K | $106.19K | ||||||
Derivative Transactions0
No derivative transactions reported